Usa1p is a recently discovered member of the HRD ubiquitin ligase complex. The HRD pathway is a conserved route of ubiquitin-dependent, endoplasmic reticulum (ER)-associated degradation (ERAD) of numerous lumenal (ERAD-L) and membrane-anchored (ERAD-M) substrates. We have investigated Usa1p to understand its importance in HRD complex action. Usa1p was required for the optimal function of the Hrd1p E3 ubiquitin ligase; its loss caused deficient degradation of both membrane-associated and lumenal proteins. Furthermore, Usa1p functioned in regulation of Hrd1p by two mechanisms. First, Hrd1p self-degradation, which serves to limit the levels of uncomplexed E3, is absolutely dependent on Usa1p and the ubiquitin-like (Ubl) domain of Usa1p. We found that Usa1p allows Hrd1p degradation by promoting trans interactions between Hrd1p molecules. The Ubl domain of Usa1p was required specifically for Hrd1p self-ubiquitination but not for degradation of either ERAD-L or ERAD-M substrates. In addition, Usa1p was able to attenuate the activity-dependent toxicity of Hrd1p without compromising substrate degradation, indicating a separate role in ligase regulation that operates in parallel to stability control. Many of the described actions of Usa1p are distinct from those of Der1p, which is recruited to the HRD complex by Usa1p. Thus, this novel, conserved factor is broadly involved in the function and regulation of the HRD pathway of ERAD.
ER3 -associated degradation (ERAD) is a conserved process by which eukaryotic cells target and degrade ER-resident proteins by the ubiquitin-proteasome pathway. ERAD pathways play a major role in the destruction of misfolded or unassembled ER proteins, including both lumenal and integralmembrane substrates. In addition, normal proteins are regulated by this pathway, the most prominent case being the sterol pathway-regulated degradation of HMG-CoA reductase in both yeast and mammals (1, 2). Eukaryotic ERAD is brought about by the action of multiple pathways of ubiquitin-mediated degradation that operate at the ER surface (3, 4).Covalent addition of ubiquitin to proteins brings about their recognition and degradation by the cytosolic 26S proteasome. Protein ubiquitination occurs by a cascade of enzymes that add 7.6-kDa ubiquitin to the targeted protein. The E1 ubiquitinactivating enzyme first forms a high energy bond with ubiquitin in an ATP-dependent reaction, and then the ubiquitin is transferred to an E2, or ubiquitin-conjugating enzyme. E2-bound ubiquitin is next transferred from the charged E2 to the target protein by the action of a ubiquitin ligase, or E3, that ensures specificity of transfer to the proper degradation substrate. The action of the E3 is iterative, causing the construction of a substrate-bound multiubiquitin chain that is recognized by the 26S proteasome (5). Several E3 ubiquitin ligases are involved in the destruction of ER proteins. Thus, ERAD is a composite of ubiquitination pathways with distinct ligases that use both separate and common components to effect recognition,...